ROLE OF CYTOPLASMIC MARKERS AS PRIMARY PANEL FOR IMMUNOPHENOTYPING OF ACUTE LEUKEMIA IN PEDIATRIC POPULATION- A SINGLE CENTRE STUDY

Dr. Nisha Khanna, Dr. Biren Parikh, Dr. Priti Trivedi, Dr. Hemangini Vora

Abstract


INTRODUCTION: Flow cytometry is highly sensitive for detection and quantitative analysis of surface and intracellular antigens in malignant hemopoieticcells and is used for classification and lineage assignment of acute leukemia. AIM- To identify the role of a single 5 colour, CD45, myeloperoxidase (MPO), cCD79a, cCD3, and Tdt, cytoplasmic markers combination as a primary tube and comparison with final diagnosis done on the basis of morphology and primary and secondary panels in immunophenotyping. MATERIALS AND METHODS: We have included 200 new cases of pediatric acute leukemia. We analyzed sensitivity and specificity of different subsets with combination of positive and negative markers. RESULTS: MPO was positive in 76.9% of acute myeloid leukemia (AML) cases. All 39 (100%) cases of the AML were negative for cCD3 andcCD79a co‑expression. cCD79a expression was highly sensitive as 97.7% B‑acute lymphoblastic leukemia (B‑ALL) expressed it. cCD3 expression was detected in 100% cases of T‑ALL, and its co‑expression was not seen in B‑ALL and AML. CONCLUSION: Our study indicates that there was very good correlation of 5‑color cytoplasmic tube‑based diagnosis versus final diagnosis based on morphology, cytochemistry, and flow cytometry. We can use this 5‑color cytoplasmic tube method to make immunophenotyping cost‑effective.


Keywords


Acute leukemia, cytoplasmic antigens, flow cytometry.

Full Text:

PDF

References


Salem DA, Abd El‑Aziz SM. Flowcytometric immunophenotypic profile of acute leukemia: Mansoura experience. Indian J Hematol Blood Transfus2012;28:89‑96.

Venkateshwaran SP, Jojo A, Vidhyadharan G, Unni M. A clinicopathological correlation of acute leukemia in relation to immunophenotyping and cytogenetics 2015. Int J Collab Res Intern Med Public Health 2012;4:1713‑37.

Osman IM, Humeida AA, Eltayeb O, Abdelrhman I, Elhadi TA. Flow cytometric immunophenotypic characterization of acute leukemia in Sudan. Int J HematolDisord2015;2:10‑7.

Knapp W, Strobl H, Majdic O. Flow cytometric analysis of cell‑surface and intracellular antigens in leukemia diagnosis. Cytometry 1994;18:187‑98.

Mirro J, Zipf TF, Pui CH, Kitchingman G, Williams D, Melvin S, et al. Acute mixed lineage leukemia: Clinicopathologic correlations and prognostic significance. Blood. 1985;66:1115‑23.

Janossy G, Coustan‑Smith E, Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: A study of 500 cases. Leukemia1989;3:170‑81.

Pui CH, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993;82:343‑62.

Borowitz MJ. Immunologic markers in childhood acute lymphoblastic leukemia. HematolOncolClin North Am 1990;4:743‑65.

Koju S, Sachdeva MU, Bose P, Varma N. Spectrum of acute leukemia diagnosed on flow cytometry: Analysis from tertiary care from North India. Ann Clin Chem Lab Med 2015;1:12‑5.

Shreshtha S, Shreshtha J, Pun CB, Pathak T, Bastola S, Bhatta R. Immunophenotypic study of acute leukemia by flow cytometry at BPKMCH. J Pathol Nepal 2013;3:345‑50.

Storr J, Dolan G, Coustan‑Smith E, Barnett D, Reilly JT. Value of monoclonal anti‑myeloperoxidase (MPO7) for diagnosing acute leukaemia. J Clin Pathol1990;43:847‑9.

Sharma RK, Puri V, Mutereja D, Kumar S, Chauhan P, Purohit A, et al. Applicability of a single 5 color cytoplasmic tube as primary panel in routine immunophenotyping of acute leukemia. J Blood DisordTransfus2015;6:1‑5.

Renate TS, Mitterbauer G, Simonitsch I, Jaeger U, Lechner K, Schneider B, et al. The immunophenotype of 325 adult acute leukemias: Relationshipto morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol2002;117:380‑9.

Sartor M, Bradstock K. Detection of intracellular lymphoid differentiation antigens by flow cytometry in acute lymphoblastic leukemia. Cytometry 1994;18:119‑22.

Van der Schoot CE, Daams GM, Pinkster J, Vet R, von dem Borne AE. Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukaemia. Br J Haematol1990;74:173‑8.

Van der Schoot CE, von dem Borne AE, Tetteroo PA. Characterization of myeloid leukemia by monoclonal antibodies, with an emphasis on antibodies against myeloperoxidase. ActaHaematol 1987;78 Suppl 1:32‑40.

Dworzak MN, Fritsch G, Fröschl G, Printz D, Gadner H. Four‑color flow cytometric investigation of terminal deoxynucleotidyl transferase‑positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B‑cell ontogeny. Blood 1998;92:3203‑9.

Mason DY, Cordell JL, Tse AG, van Dongen JJ, van Noesel CJ, Micklem K, et al. The IgM‑associated protein mb‑1 as a marker of normal andneoplastic B cells. J Immunol 1991;147:2474‑82.

Rani S, De Oliveira MS, Catovsky D. Different expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides. HematolPathol1988;2:73‑8.


Refbacks

  • There are currently no refbacks.